Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice

Journal of Neurochemistry

Volumn 72, Issue 4, 1999, Pages 1625-1633

  Song, Dong Keun ^a   Im, Yeong Bin ^a   Jung, Jun Sub ^a   Suh, Hong Won ^a   Huh, Sung Oh ^a   Park, Sang Wook ^a   Wie, Myung Bok ^b   Kim, Yung Hi ^a  

^a Hallym University   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

6 Hydroxydopamine; Interleukin 6; Intracerebroventricular; Lipopolysaccharide; Norepinephrine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 6; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

ADRENAL GLANDS; ANIMALS; BRAIN CHEMISTRY; CHOROID PLEXUS; CORTICOSTERONE; GENE EXPRESSION; HYPOTHALAMUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; NOREPINEPHRINE; OXIDOPAMINE; PITUITARY GLAND; RNA, MESSENGER; SYMPATHOLYTICS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0032998630     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.721625.x     Document Type: Article

References (48)

1. Akiyoshi M., Shimizu Y., and Saito M. (1990) Interleukin-1 increases norepinephrine turnover in the spleen and lung in rats. Biochem. Biophys. Res. Commun. 173, 1266-1270.
2. Altenburg S. P., Martins M. A., Silva A. R., Cordeiro R. S., and Castro-Faria-Neto H. C. (1997) LPS-induced blood neutrophilia is inhibited by alpha 1-adrenoceptor antagonists: a role for catecholamines. J. Leukocyte Biol. 61, 689-694.
3. Andersson P.-B., Perry V. H., and Gordon S. (1992) The acute inflammatory response to lipopolysaccharide in the CNS parenchyma differs from that in other body tissues. Neuroscience 48, 169-186.
4. 2B/2C-adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits. Brain Res. 705, 302-306.
5. Benveniste E. N., Sparacio S. M., Norris J. G., Grenett H. E., and Fuller G. M. (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30, 201-212.
6. Billiar T. R., Curran R. D., Williams D. L., and Kispert P. H. (1992) Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation. Arch. Surg. 127, 31-37.
7. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
8. Cross R. J. and Roszman T. L. (1988) Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation. J. Neuroimmunol. 19, 33-45.
9. Cross R. J., Jackson J. C., Brooks W. H., Sparks W. H., Markesbery W. R., and Roszman T. L. (1986) Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology 57, 145-152.
10. Cross R. J., Brooks W. H., and Roszman T. L. (1987) Modulation of T-suppressor cell activity by central nervous system catecholamine depletion. J. Neurosci. Res. 18, 75-81.
11. Delrue-Perollet C., Li K.-S., Vitiello S., and Neveu P. J. (1995) Peripheral catecholamines are involved in the neuroendocrine and immune effects of LPS. Brain Behav. Immun. 9, 149-162.
12. De Luigi A., Terreni L., Sironi M., and De Simoni M. G. (1998) The sympathetic nervous system tonically inhibits peripheral interleukin-1β and interleukin-6 induction by central lipopolysaccharide. Neuroscience 83, 1245-1250.
13. DeRijk R. H., Boelen A., Tilders F. J. H., and Berkenbosch F. (1994) Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 19, 155-163.
14. De Simoni M. G., Sironi M., De Luigi A., Manfridi A., Mantovani A., and Ghezzi P. (1990) Intracerebroventricular injection of interleukin-1 induces high circulating levels of interleukin-6. J. Exp. Med. 171, 1773-1778.
15. De Simoni M. G., De Luigi A., Gemma L., Sironi M., Manfridi A., and Ghezzi P. (1993) Modulation of systemic interleukin-6 induction by central interleukin-1. Am. J. Physiol. 265 (Regul. Integrative Comp. Physiol. 34), R739-R742.
16. De Simoni M. G., del Bo R., De Luigi A., Simard S., and Forloni G. (1995) Central endotoxin induces different patterns of interleukin (IL)-1β and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology 136, 897-902.
17. Dunn A. J. (1992) Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol. Exp. Ther. 26, 964-969.
18. Faulkner C. B., Simecka J. W., Davidson M. K., Davis J. K., Schoeb T. R., Lindsey J. R., and Everson M. P. (1995) Gene expression and production of tumor necrosis alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect. Immun. 63, 4084-4090.
19. Finck B. N., Dantzer R., Kelly K. W., Woods J. A., and Johnson R. W. (1997) Central lipopolysaccharide elevates plasma IL-6 concentration by an α-adrenoceptor-mediated mechanism. Am. J. Phvsiol. 272 (Regul. Integrative Comp. Physiol. 41), R1880-R1887.
20. Frei K., Malipiero U. V., Leist T. P., Zinkernagel R. M., Schwab M. E., and Fontana A. (1989) On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19, 689-694.
21. Glick D., Redlich D. V., and Levine S. (1964) Fluorometric determination of corticosterone and cortisol in 0.02-0.05 milliliters of plasma or submilligram samples of adrenal tissue. Endocrinology 74, 653-655.
22. Gottschall P. E., Komaki G., and Arimura A. (1992) Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide. Neuroendocrinology 56, 935-938.
23. Haley T. J. and McCormick W. G. (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12, 12-15.
24. Hirano T. (1998) Interleukin-6, in The Cytokine Handbook (Thomson A., ed), pp. 197-228. Academic Press, London.
25. Huang Q.-H., Takaki A., and Arimura A. (1997) Central noradrenergic system modulates plasma interleukin-6 production by peripheral interleukin-1. Am. J. Physiol. 273 (Regul. Integrative Comp. Physiol. 42), R731-R738.
26. Judd A. M., Spangelo B. L., and MacLeod R. M. (1990) Rat adrenal zona glomerulosa cells produce interleukin 6. Prog. Neuroendocrin. Immunol. 3, 282-292.
27. Kitamura H., Konno A., Morimatsu M., Jung B. D., Kimura K., and Saito M. (1997) Immobilization stress increases hepatic IL-6 expression in mice. Biochem. Biophys. Res. Commun. 238, 707-711.
28. Kitamura H., Okamoto S., Shimamoto Y., Morimatsu M., Terao A., and Saito M. (1998) Central IL-1 differentially regulates peripheral IL-6 and TNF synthesis. Cell. Mol. Life Sci. 54, 282-287.
29. Komaki G., Gottschall P. E., Somogyvari-Vigh A., Tatsuno I., Yatohgo T., and Arimura A. (1994) Rapid increase in plasma interleukin-6 after hemorrhage, and posthemorrhage reduction of the IL-6 response to LPS, in conscious rats: interrelation with plasma corticosterone levels. Neuroimmunomodulation 1, 127-134.
30. Kostrzewa R. M. and Jacobowitz D. M. (1977) Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26, 199-288.
31. Kukielka G. L., Youker K. A., Michael L. H., Kumar A. G., Ballantyne C. M., Smith C. W., and Entman M. L. (1995) Role of early reperfusion in the induction of adhesion molecules and cytokines in previously ischemic myocardium. Mol. Cell. Biochem. 147, 5-12.
32. Laursen S. E. and Belknap J. K. (1986) Intracerebroventricular injections in mice. J. Pharmacol. Methods 16, 355-357.
33. LeMay L. G., Otterness I. G., Vander A. J., and Kluger M. J. (1990) In vivo evidence that the rise in plasma IL-6 following injection of a fever-inducing dose of LPS is mediated by IL-1β. Cytokine 2, 199-204.
34. Liao J., Keiser J. A., Scales W. E., Kunkel S. L., and Kluger M. J. (1995) Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am. J. Physiol. 268 (Regul. Integrative Comp. Phvsiol. 37), R896-R901.
35. Madden K. S. and Felten D. L. (1995) Experimental basis for neural-immune interactions. Physiol. Rev. 75, 77-106.
36. Madden K. S., Moynihan J. A., Brenner G. J., Felten S. Y., Felten D. L., and Livnat S. (1994) Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunol. 49, 77-87.
37. Muramami N., Fukata J., Tsukada T., Kobayashi H., Ebisui O., Segawa H., Muro S., Imura H., and Nakao K. (1993) Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology 133, 2574-2578.
38. Neumann F. J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., and Schomig A. (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92, 748-755.
39. Nonogaki K., Moser A. H., Feingold K. R., and Grunfeld C. (1994) α-Adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor in rats. Endocrinology 135, 2644-2650.
40. Papanicolaou D. A., Petrides J. S., Tsigos C. Bina S., Kalogeras K. T., Wilder R., Gold P. W., Deuster P. A., and Chrousos G. P. (1996) Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholammes. Am. J. Physiol. 271 (Endocrinol. Metab. 34), E601-E605.
41. Romero L. I., Kakucska I., Lechan R. M., and Reichlin S. (1996) Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1β in rats. Am. J. Physiol. 270 (Regul. Integrative Comp. Physiol 39), R518-R524.
42. Suaudeau C. Dourmap N., and Costentin J. (1995) Rapid and long lasting reduction of the hypothalamic effect of a D2 dopamine agonist after an intracerebroventricular injection of 6-hydroxydopamine. Neuropharmacology 34, 101-105.
43. Takahashi A., Ikarashi Y., Ishimaru H., and Maruyama Y. (1993) Compensation between sympathetic nerves and adrenal medullary activity: effects of adrenodemedullation and chemical sympatheclomy on catecholamine turnover. Life Sci. 53, 1567-1572.
44. Takaki A., Huang Q. H., Somogyvari-Vigh A., and Arimura A. (1994) Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1, 335-342.
45. Terebuh P. D., Otterness I. G., Stricter R. M. Lincoln P. M., Danforth J. M., Kunkel S. L., and Chensue S. W. (1992) Biologic and immunohistochemical analysis of interleukin-6 expression in vivo. Constitutive and induced expression in murine polymorphonuclear and mononuclear phagocytes. Am. J. Pathol. 140, 649-657.
46. Van Gool J., Van Vugt H., Helle M., and Aardcn L. A. (1990) The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin. Immunol. Immunopathol. 57, 200-210.
47. Vankelecom H., Carmeliet P., Damme J. V., Billiau A., and Denef C. (1989) Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 49, 102-106.
48. Zhou D., Kusnecov A. W., Shurin M. R., Depaoli M. and Rabin B. S. (1993) Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133, 2523-2530.